We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $18.50, moving -2.48% from the previous trading session. This change lagged the S&P 500's daily gain of 0.44%. Elsewhere, the Dow gained 0.14%, while the tech-heavy Nasdaq added 0.7%.
The stock of company has risen by 12.92% in the past month, leading the Finance sector's gain of 3.79% and the S&P 500's gain of 4.03%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.55 per share. This would mark a year-over-year decline of 150%. Our most recent consensus estimate is calling for quarterly revenue of $3.09 billion, up 27.51% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.42 per share and revenue of $12.06 billion, indicating changes of -1520% and +31.44%, respectively, compared to the previous year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Oscar Health, Inc. is holding a Zacks Rank of #5 (Strong Sell) right now.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 70, placing it within the top 29% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $18.50, moving -2.48% from the previous trading session. This change lagged the S&P 500's daily gain of 0.44%. Elsewhere, the Dow gained 0.14%, while the tech-heavy Nasdaq added 0.7%.
The stock of company has risen by 12.92% in the past month, leading the Finance sector's gain of 3.79% and the S&P 500's gain of 4.03%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.55 per share. This would mark a year-over-year decline of 150%. Our most recent consensus estimate is calling for quarterly revenue of $3.09 billion, up 27.51% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.42 per share and revenue of $12.06 billion, indicating changes of -1520% and +31.44%, respectively, compared to the previous year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Oscar Health, Inc. is holding a Zacks Rank of #5 (Strong Sell) right now.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 70, placing it within the top 29% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.